Stroke
Conference Coverage
Conference News Roundup—European Stroke Organization
Patients with intracerebral hemorrhage may benefit from receiving a drug currently used to treat blood loss from major trauma...
Conference Coverage
Data Indicate Disparities in IV t-PA Administration
LOS ANGELES—Variables such as age, sex, race, and insurance status predict whether a patient with ischemic stroke will receive IV...
Conference Coverage
What Is the Prevalence of Sleep Disorders in Neurologic Populations?
LOS ANGELES—About one-third of neurologic patients has a high risk of obstructive sleep apnea (OSA), and approximately one-...
Conference Coverage
TAVR-related stroke risk unrelated to anatomy
PARIS – “Cerebroembolic protection is like a seat belt: You should wear it. All patients should wear it.” – Saibal Kar, MD.
Conference Coverage
Amplatzer Amulet slashes stroke risk in A-fib
PARIS – “Given the high bleeding risk, single antiplatelet therapy seems to be a good option for these patients,” said Dr. Ulf Landmesser.
Conference Coverage
Midlife retinopathy predicts ischemic stroke
LOS ANGELES – No tie to hemorrhagic strokes observed in review of more than 10,000 patients followed for nearly 20 years.
Literature Review
Risk of Recurrent ICH Is Higher Among Blacks and Hispanics
Compared with their white peers, black and Hispanic patients with intracerebral hemorrhage (ICH) have a higher risk of recurrence, according to...
Conference Coverage
Antidepressant therapy after MI, stroke cut CVD events
Insufficient treatment of major depressive disorder after MI or stroke is linked to higher risk of recurrent cardiovascular events.
Conference Coverage
DMTs Are Associated With Reduced Stroke Risk in Patients With MS
LOS ANGELES—Among patients with multiple sclerosis (MS), treatment with disease-modifying therapy is associated with a significantly decreased...
Conference Coverage
Blood Pressure Change Influences Outcome of Endovascular Therapy
LOS ANGELES—Decreases in blood pressure during endovascular therapy are common and associated with worse functional outcomes, according to...
Conference Coverage
Interferon treatment does not increase stroke risk in MS
Pooled data from 17 trials, as well as postmarketing surveillance data, show no increase in stroke risk with interferon treatment in MS patients...